Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo.

Gunnar Wichmann; Susan Cedra; Daphne Schlegel; Marlen Kolb; Susanne Wiegand; Andreas Boehm; Mathias Hofer; Andreas Dietz

doi:10.21873/anticanres.11344

Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo.

Gunnar Wichmann
, Susan Cedra
, Daphne Schlegel (Co-author)
, Marlen Kolb
, Susanne Wiegand
, Andreas Boehm
, Mathias Hofer
, Andreas Dietz

Department of Oral and Maxillofacial Surgery

Research output: Contribution to journal › Original Article › peer-review

11 Citations (Web of Science)

Original language	English
Pages (from-to)	521-527
Journal	ANTICANCER RESEARCH
Volume	37
Issue number	2
DOIs	https://doi.org/10.21873/anticanres.11344
Publication status	Published - 2017

Keywords

ENDOTHELIAL GROWTH-FACTOR
PHASE-I/II TRIAL
PLUS CETUXIMAB
TUMOR-GROWTH
SERUM-LEVELS
CANCER
ANGIOGENESIS
EXPRESSION
VEGF
INTERLEUKIN-6

Access to Document

10.21873/anticanres.11344

Cite this

Wichmann, G., Cedra, S., Schlegel, D., Kolb, M., Wiegand, S., Boehm, A., Hofer, M., & Dietz, A. (2017). Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo. ANTICANCER RESEARCH , 37(2), 521-527. https://doi.org/10.21873/anticanres.11344

Wichmann, Gunnar ; Cedra, Susan ; Schlegel, Daphne et al. / Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo. In: ANTICANCER RESEARCH 2017 ; Vol. 37, No. 2. pp. 521-527.

@article{ae78c9ebed424100ac726a2e9e217283,

title = "Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo.",

keywords = "ENDOTHELIAL GROWTH-FACTOR, PHASE-I/II TRIAL, PLUS CETUXIMAB, TUMOR-GROWTH, SERUM-LEVELS, CANCER, ANGIOGENESIS, EXPRESSION, VEGF, INTERLEUKIN-6",

author = "Gunnar Wichmann and Susan Cedra and Daphne Schlegel and Marlen Kolb and Susanne Wiegand and Andreas Boehm and Mathias Hofer and Andreas Dietz",

note = "Schlegel: Department of Cranio-Maxillo-Facial Surgery, Paracelsus Medical University Nuremberg Hospital South, Nuremberg, Germany.",

year = "2017",

doi = "10.21873/anticanres.11344",

language = "English",

volume = "37",

pages = "521--527",

journal = "ANTICANCER RESEARCH ",

issn = "0250-7005",

number = "2",

}

Wichmann, G, Cedra, S, Schlegel, D, Kolb, M, Wiegand, S, Boehm, A, Hofer, M & Dietz, A 2017, 'Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo.', ANTICANCER RESEARCH , vol. 37, no. 2, pp. 521-527. https://doi.org/10.21873/anticanres.11344

Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo. / Wichmann, Gunnar; Cedra, Susan; Schlegel, Daphne (Co-author) et al.
In: ANTICANCER RESEARCH , Vol. 37, No. 2, 2017, p. 521-527.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo.

AU - Wichmann, Gunnar

AU - Cedra, Susan

AU - Schlegel, Daphne

AU - Kolb, Marlen

AU - Wiegand, Susanne

AU - Boehm, Andreas

AU - Hofer, Mathias

AU - Dietz, Andreas

N1 - Schlegel: Department of Cranio-Maxillo-Facial Surgery, Paracelsus Medical University Nuremberg Hospital South, Nuremberg, Germany.

PY - 2017

Y1 - 2017

KW - ENDOTHELIAL GROWTH-FACTOR

KW - PHASE-I/II TRIAL

KW - PLUS CETUXIMAB

KW - TUMOR-GROWTH

KW - SERUM-LEVELS

KW - CANCER

KW - ANGIOGENESIS

KW - EXPRESSION

KW - VEGF

KW - INTERLEUKIN-6

U2 - 10.21873/anticanres.11344

DO - 10.21873/anticanres.11344

M3 - Original Article

C2 - 28179297

SN - 0250-7005

VL - 37

SP - 521

EP - 527

JO - ANTICANCER RESEARCH

JF - ANTICANCER RESEARCH

IS - 2

ER -

Wichmann G, Cedra S, Schlegel D, Kolb M, Wiegand S, Boehm A et al. Cilengitide and Cetuximab Reduce Cytokine Production and Colony Formation of Head and Neck Squamous Cell Carcinoma Cells Ex Vivo. ANTICANCER RESEARCH . 2017;37(2):521-527. doi: 10.21873/anticanres.11344